Cecilia C. Maramba-Lazarte และผู้แต่งคนอื่นๆ. (2022) Symptomatic treatment of mild COVID-19 with Vitex negundo(NIRPROMP formulation):A randomized, controlled clinical trial. <i>Journal of Basic and Applied Pharmacology</i>, <i>2</i>(2), O88-109.Cecilia C. Maramba-Lazarte และผู้แต่งคนอื่นๆ. "Symptomatic treatment of mild COVID-19 with Vitex negundo(NIRPROMP formulation):A randomized, controlled clinical trial". Journal of Basic and Applied Pharmacology 2 (2022):O88-109.Cecilia C. Maramba-Lazarte และผู้แต่งคนอื่นๆ. Symptomatic treatment of mild COVID-19 with Vitex negundo(NIRPROMP formulation):A randomized, controlled clinical trial. The Pharmacological and Therapeutic Society of Thailand:ม.ป.ท. 2022.